ArticleCellular and molecular life sciences : CMLS2025
Neutrophilic granule protein promotes lipopolysaccharide-induced iNOS/NO expression via JAK2/STAT1 signaling pathway and augments bacteria clearance of macrophages.
Article in Cellular and molecular life sciences : CMLS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Mature-StageInternational journal of molecular sciences · 2026Article
- Microbiota-immune crosstalk in the regulation of intestinal motility in constipation.Frontiers in microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
Neutrophilic granule protein (NGP) was identified as a granular protein in neutrophils, but its function in macrophages has not been fully understood. In our prior investigation, NGP was observed to be significantly upregulated in macrophages following stimulation with lipopolysaccharide (LPS) or Escherichia coli (E.coli). Furthermore, NGP demonstrated an anti-inflammatory effect by inhibiting the NF-κB signaling pathway through its extracellular distribution. Nitric oxide (NO), as a crucial factor in the immune regulation of macrophages mainly controlled by inducible nitric oxide synthase (iNOS), plays an indispensable role in the eradication of bacteria. However, the regulatory effects of NGP on NO remains unknown. In this study, we observed an upregulation and central role of Nos2, the gene encoding iNOS, in macrophages with high NGP expression induced by LPS. Overexpression of NGP significantly enhanced NO production in LPS-induced macrophages, while NGP knockout attenuated NO production. Furthermore, exogenous complementation experiments confirmed that NGP primarily exerted its up-regulatory effect on iNOS/NO through intracellular distribution. Additionally, RNA sequencing (RNA-seq) and immunoprecipitation-mass spectrometry (IP-MS) analyses revealed that NGP predominantly regulated NO levels via the JAK2/STAT1 pathway. Finally, our in vitro and in vivo experiments provided evidence supporting the involvement of NGP in bacterial clearance through modulation of NO. The evidence suggests that NGP plays a crucial role in regulating NO production and promoting bacterial clearance in macrophages, making it a promising target for the prevention and treatment of infectious diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.